The reduction in inflammatory factors such as TNF-α and IL-6, as well as the decreased expression of the important inflammatory pathway NF-κB/COX-2/PGE2, contributed to the effective control of asthma-related changes. The gene discussed is PTGS2; the disease is asthma.